Thus far, research into AXL in breast cancer has clearly demonstrated an oncogenic role for this receptor in various breast cancer subtypes, as it is upregulated in breast cancer tumors and can promote tumor formation, EMT, metastasis, and chemoresistance through stimulation of an abundance of intracellular signaling pathways. The gene discussed is AXL; the disease is neoplasm.